About Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate
Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate is a rare disease catalogued by Orphanet (ORPHA:615964). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate trials.
Search ClinicalTrials.gov for "Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate" or Orphanet code ORPHA:615964 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate. Updated daily.